Dr. Soma Sahai-Srivastava, MD

Dr. Sahai-Srivastava practices at USC University Hospital in Los Angeles, California.

Dr. Sahai-Srivastava's NPI, 1215964556, was assigned on June 26, 2006. Dr. Sahai-Srivastava graduated from Patna Medical College in 1991. Dr. Sahai-Srivastava holds California license A65294.

Dr. Sahai-Srivastava's primary practice is USC University Hospital, at 1520 N San Pablo St, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-5100.

Dr. Sahai-Srivastava's primary practice is USC University Hospital in Los Angeles, California. Dr. Sahai-Srivastava is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Sahai-Srivastava to 1 more hospital, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sahai-Srivastava practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sahai-Srivastava's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sahai-Srivastava is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Sahai-Srivastava is licensed in California.

Dmand AI lists hereditary polyneuropathy, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain, neuropathy, thoracic spine disorders and vertigo among the conditions Dr. Sahai-Srivastava treats.

CMS data shows 493 Medicare services from Dr. Sahai-Srivastava across 8 procedure codes in 2024, for 187 Medicare patients. Medicare paid $31,827 for them.

CMS counts 187 Medicare patients who saw Dr. Sahai-Srivastava in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high cholesterol, and 71% have arthritis. 40% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sahai-Srivastava's median patient age at 51, with 76% women.

In 2024, Dr. Sahai-Srivastava wrote 69 Medicare Part D claims. 16% of them were for generic drugs. CMS names the drug for 58 of them, across 2 drugs with 11 or more claims each, at $590,958 in total drug cost. In 2023, CMS named 44 claims across 1 drug.

Dr. Sahai-Srivastava accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sahai-Srivastava as offering telehealth.

Dmand AI links 2 papers to Dr. Sahai-Srivastava, published from 2010 to 2021. Dr. Sahai-Srivastava's most frequent co-authors are Zubair Ahmed, MD, Maike Tiede Blaya, MD and Melissa M. Cortez, DO.

Dmand AI links Dr. Sahai-Srivastava to 3 clinical trials. Conditions studied include Cluster Headache, Trigeminal Autonomic Cephalalgias and Migraine Disorders.

CMS Open Payments shows 133 general payments to Dr. Sahai-Srivastava from 12 drug and device companies from 2016 to 2025. Grants make up the largest share, 64% of the total. Pfizer Inc. paid the most, $80,000.

Dr. Sahai-Srivastava graduated from Patna Medical College in 1991.

Dr. Sahai-Srivastava is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.